CasInvent Pharma
Description: CasInvent Pharma develops selective small-molecule inhibitors targeting CK1 kinases for leukemia treatment, advancing preclinical lead compounds.
Country: Czechia
Based in: Brno
Founded: 2020
Funding Stage: Seed
Tags: ['Pharmaceutical Manufacturing', 'Treatment of Leukemias', 'identification of new drugs for the treatment']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
